TXG
10X Genomics Inc
79.10$
+3.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 14.9% | 19.6% | 24.8% | 19.6% | 15.1% | 23.3% | 33.8% | 32.1% | 30.9% | |
| 85.1% | 80.4% | 75.2% | 80.4% | 84.9% | 76.7% | 66.2% | 67.9% | 69.1% | |
| 45.2% | 32.5% | 33.8% | 41.3% | 43.2% | 51.4% | 43.7% | 43.3% | 37.1% | |
| 65.5% | 59.6% | 52.6% | 67.1% | 51.6% | 57.0% | 55.0% | 55.7% | 49.2% | |
| 111.0% | 92.6% | 87.0% | 109.0% | 95.7% | 109.2% | 109.0% | 99.7% | 86.3% | |
| -25.8% | -75.7% | -11.8% | -28.6% | -10.8% | -32.5% | -42.9% | -31.9% | -17.2% | |
| 1.1% | 1.6% | 1.3% | 0.6% | 0.2% | 0.1% | 0.0% | 0.0% | 0.0% | |
| -26.4% | -76.8% | -12.6% | -178.8% | -11.0% | -31.4% | -40.2% | -29.1% | -6.2% | |
| 0.0% | 0.1% | 0.1% | 2.8% | 0.9% | 0.8% | 1.0% | 0.8% | 0.6% | |
| -26.4% | -76.9% | -12.7% | -181.6% | -11.9% | -32.1% | -41.2% | -29.9% | -6.8% | |
| -19.2% | -72.5% | -8.5% | -171.9% | -5.0% | -24.9% | -33.2% | -21.9% | 0.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.